A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Vinflunine+Gemcitabine|DRUG: Paclitaxel+Gemcitabine
Sponsor: Pierre Fabre Medicament